Gout
📧 Sign up to get email alerts when something new happens for Gout.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-19EMA Authorised: Febuxostat Viatris (previously Febuxostat Mylan) (febuxostat) — Viatris Limited
European Medicines Agency authorised Febuxostat Viatris for hyperuricemia and gout-related indications.
-
FDA approval · 2026-08-07FDA Approved: KRYSTEXXA — Supplemental Application (Horizon Therapeutics USA, Inc.)
FDA supplemental application review for KRYSTEXXA (pegloticase) submitted by Horizon Therapeutics USA, Inc.
-
CLINICAL_TRIALS trial_result · 2026-07-01Clinical Trial Results: A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout [Phase 4]
Phase 4 trial comparing pegylated uricase (pegloticase) given every 4 weeks with methotrexate vs every 2 weeks with methotrexate for uncontr…
-
CLINICAL_TRIALS trial_result · 2026-06-22Clinical Trial Results: To Evaluate the Influence of (LUA Probiotics) on Uric Acid
Clinical trial results evaluating the influence of LUA Probiotics on uric acid in gout patients have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-10Clinical Trial Results: Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With Hyperuricemia [Phase 1, Phase 2]
Open-label pharmacokinetic, pharmacodynamic, and drug-drug interaction study of dotinurad with allopurinol in gout patients with hyperuricem…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Long-Term Risk of Gout in Living Kidney Donors
A completed clinical trial update assessing the long-term risk of gout among living kidney donors.
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: A Study of Dotinurad Versus Allopurinol in Tophaceous Gout [Phase 3]
A Phase 3 clinical trial comparing dotinurad to allopurinol for tophaceous gout is currently recruiting, sponsored by Crystalys Therapeutics…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of Dotinurad Versus Allopurinol in Participants With Gout [Phase 3]
An ongoing Phase 3 clinical trial comparing dotinurad to allopurinol in patients with gout, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Study of the Correlation Between UltraSonography and Dual-Energy Computed Tomography Assessment of Urate Deposit [NA]
A completed clinical trial evaluating the correlation between ultrasound and dual-energy CT in outlining urate deposits in gout patients.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Epidemiology of Gout in French Polynesia [NA]
This document reports the completion/update of a clinical trial studying the epidemiology of gout in French Polynesia.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants [Phase 2]
Phase 2 clinical trial update evaluating dotinurad in gout patients who are intolerant to XOI or who have uricase failure; the study status …
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ Fusion Protein in the Treatment of Acute Gout [NA]
This document reports the completion of a clinical trial evaluating a recombinant human TNF receptor II fusion protein for acute gout.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Drug-Drug Interaction Study of ABP-671 in Gout Patients [Phase 1]
A Phase 1 drug-drug interaction study of ABP-671 in gout patients is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout Patients [Phase 3]
This document notes an ongoing Phase 3 therapeutic confirmatory trial comparing Epaminurad to Febuxostat in gout patients.
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout [Phase 4]
This completed Phase 4 trial assessed whether pegloticase given every 4 weeks with methotrexate is non-inferior to pegloticase every 2 weeks…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: A Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of LEO 158968 [Phase 1]
This Phase 1 trial update reports the completion of a single-dose study of LEO 158968 evaluating efficacy, safety, tolerability, pharmacokin…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Tight Control of Gouty Arthritis Compared to Usual Care [NA]
This clinical trial update reports a study comparing tight control of gouty arthritis to usual care, sponsored by the University of Edinburg…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of SHR4640 tablets in combination with febuxostat 40 mg for primary gout and hyper…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Dose Response of Exercise for Arthritis Management [NA]
A University of South Carolina-led clinical trial is investigating the dose-response effects of exercise on arthritis management and related…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout [Phase 3]
A Phase 3 randomized trial evaluating pegloticase administration by subcutaneous vs intravenous routes, both with methotrexate, in people wi…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: The Orienting Study
The Orienting Study is an ongoing clinical trial sponsored by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio. It is currently recruiting particip…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: SAVE-Care (Sodium Glucose Cotransporter-2 Inhibitors [SGLT2i] As Novel Gout Care) Trial [Phase 4]
A Phase 4 clinical trial (SAVE-Care) is evaluating sodium-glucose cotransporter-2 inhibitors as a novel approach for gout care, and the stud…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: The Effects of a Probiotic Food Supplement in Hyperuricaemia [NA]
This clinical trial is evaluating the effects of a probiotic food supplement on hyperuricemia with or without gout and is currently recruiti…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Clinical Trial of BR2251 Tablets for Patients With Primary Gout and Hyperuricemia [Phase 2]
Phase 2 clinical trial update for BR2251 tablets in primary gout with hyperuricemia; the study is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Tigulixostat (IBI128) vs Febuxostat in Gout [Phase 3]
A Phase 3 clinical trial comparing Tigulixostat (IBI128) to Febuxostat for gout is currently recruiting.